Persistent URL of this record https://hdl.handle.net/1887/104667
In Collections
This item can be found in the following collections:
![Genetic variation in CYP19A1 and occurrence of adverse events in exemestane treatment with early breast cancer patients in the Dutch TEAM trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Genetic variation in CYP19A1 and occurrence of adverse events in exemestane treatment with early breast cancer patients in the Dutch TEAM trial
- All authors
- Houtsma, D.; Fontein, D.; Straaten, T. van der; Baak-Pablo, R.; Wessels, J.A.M.; Seynaeve, C.; Velde, C.J.H.V. de; Nortier, J.W.R.; Gelderblom, H.; Guchelaar, H.J.
- Date
- 2013-05-20
- Journal
- Journal of Clinical Oncology
- Volume
- 31
- Issue
- 15